← stocks-llm New chat

BALCHEM CORP (BCPC) — insider trading

Materials · NASDAQ

BALCHEM CORP (BCPC) has 44 reported SEC Form 4 insider transactions in our data (latest 2026-02-12).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-02-12 Bengtsson Carl Martin Officer (EVP & Chief Financial Officer) Shares withheld for taxes / exercise cost 302 $177.49 $53.6K Form 4
2026-02-12 Miyata Hatsuki Officer (EVP, CLO, & Secretary) Shares withheld for taxes / exercise cost 181 $177.49 $32.1K Form 4
2026-02-12 Tignor Michael Brent Officer (SVP & Chief HR Officer) Shares withheld for taxes / exercise cost 165 $177.49 $29.3K Form 4
2026-02-12 Boned Frederic Officer (SVP/GM, Human Nutri. & Health) Shares withheld for taxes / exercise cost 203 $177.49 $36.0K Form 4
2026-02-12 Backus William A. Officer (VP & Chief Accounting Officer) Shares withheld for taxes / exercise cost 70 $177.49 $12.4K Form 4
2026-02-12 Harris Theodore L Director, Officer (Chairman, President & CEO) Shares withheld for taxes / exercise cost 844 $177.49 $149.8K Form 4
2026-02-12 Reid Martin Luther Officer (SVP Chief Supply Chain Officer) Shares withheld for taxes / exercise cost 116 $177.49 $20.6K Form 4
2026-02-12 van Gunsteren Job Leonard Officer (SVP and GM, Specialty Products) Shares withheld for taxes / exercise cost 58 $177.49 $10.3K Form 4
2026-02-11 Knutson Daniel E Director Grant / award / vesting 870 $0.00 $0 Form 4
2026-02-11 Rigaud Olivier Director Grant / award / vesting 870 $0.00 $0 Form 4
2026-02-11 Bengtsson Carl Martin Officer (EVP & Chief Financial Officer) Grant / award / vesting (derivative) 13,200 $0.00 $0 Form 4
2026-02-11 Bengtsson Carl Martin Officer (EVP & Chief Financial Officer) Shares withheld for taxes / exercise cost 2,416 $178.68 $431.7K Form 4
2026-02-11 Bengtsson Carl Martin Officer (EVP & Chief Financial Officer) Grant / award / vesting 4,718 $0.00 $0 Form 4
2026-02-11 Bengtsson Carl Martin Officer (EVP & Chief Financial Officer) Grant / award / vesting 3,610 $0.00 $0 Form 4
2026-02-11 Miyata Hatsuki Officer (EVP, CLO, & Secretary) Grant / award / vesting (derivative) 6,300 $0.00 $0 Form 4
2026-02-11 Miyata Hatsuki Officer (EVP, CLO, & Secretary) Shares withheld for taxes / exercise cost 877 $178.68 $156.7K Form 4
2026-02-11 Miyata Hatsuki Officer (EVP, CLO, & Secretary) Grant / award / vesting 2,247 $0.00 $0 Form 4
2026-02-11 Miyata Hatsuki Officer (EVP, CLO, & Secretary) Grant / award / vesting 1,710 $0.00 $0 Form 4
2026-02-11 Tignor Michael Brent Officer (SVP & Chief HR Officer) Grant / award / vesting (derivative) 4,400 $0.00 $0 Form 4
2026-02-11 Tignor Michael Brent Officer (SVP & Chief HR Officer) Shares withheld for taxes / exercise cost 991 $178.68 $177.1K Form 4
2026-02-11 Tignor Michael Brent Officer (SVP & Chief HR Officer) Grant / award / vesting 1,929 $0.00 $0 Form 4
2026-02-11 Tignor Michael Brent Officer (SVP & Chief HR Officer) Grant / award / vesting 1,200 $0.00 $0 Form 4
2026-02-11 Boned Frederic Officer (SVP/GM, Human Nutri. & Health) Grant / award / vesting (derivative) 10,500 $0.00 $0 Form 4
2026-02-11 Boned Frederic Officer (SVP/GM, Human Nutri. & Health) Shares withheld for taxes / exercise cost 1,151 $178.68 $205.7K Form 4
2026-02-11 Boned Frederic Officer (SVP/GM, Human Nutri. & Health) Grant / award / vesting 2,247 $0.00 $0 Form 4
2026-02-11 Boned Frederic Officer (SVP/GM, Human Nutri. & Health) Grant / award / vesting 2,870 $0.00 $0 Form 4
2026-02-11 Backus William A. Officer (VP & Chief Accounting Officer) Grant / award / vesting (derivative) 1,800 $0.00 $0 Form 4
2026-02-11 Backus William A. Officer (VP & Chief Accounting Officer) Shares withheld for taxes / exercise cost 865 $178.68 $154.6K Form 4
2026-02-11 Backus William A. Officer (VP & Chief Accounting Officer) Grant / award / vesting 1,664 $0.00 $0 Form 4
2026-02-11 Backus William A. Officer (VP & Chief Accounting Officer) Grant / award / vesting 490 $0.00 $0 Form 4
2026-02-11 Graham George Officer (SVP and Chief R&D Officer) Grant / award / vesting (derivative) 2,600 $0.00 $0 Form 4
2026-02-11 Graham George Officer (SVP and Chief R&D Officer) Grant / award / vesting 700 $0.00 $0 Form 4
2026-02-11 Harris Theodore L Director, Officer (Chairman, President & CEO) Grant / award / vesting (derivative) 26,900 $0.00 $0 Form 4
2026-02-11 Harris Theodore L Director, Officer (Chairman, President & CEO) Shares withheld for taxes / exercise cost 9,358 $178.68 $1.67M Form 4
2026-02-11 Harris Theodore L Director, Officer (Chairman, President & CEO) Grant / award / vesting 18,291 $0.00 $0 Form 4
2026-02-11 Harris Theodore L Director, Officer (Chairman, President & CEO) Grant / award / vesting 7,350 $0.00 $0 Form 4
2026-02-11 Reid Martin Luther Officer (SVP Chief Supply Chain Officer) Grant / award / vesting (derivative) 3,400 $0.00 $0 Form 4
2026-02-11 Reid Martin Luther Officer (SVP Chief Supply Chain Officer) Shares withheld for taxes / exercise cost 1,085 $178.68 $193.9K Form 4
2026-02-11 Reid Martin Luther Officer (SVP Chief Supply Chain Officer) Grant / award / vesting 2,359 $0.00 $0 Form 4
2026-02-11 Reid Martin Luther Officer (SVP Chief Supply Chain Officer) Grant / award / vesting 940 $0.00 $0 Form 4
2026-02-11 van Gunsteren Job Leonard Officer (SVP and GM, Specialty Products) Grant / award / vesting (derivative) 1,600 $0.00 $0 Form 4
2026-02-11 van Gunsteren Job Leonard Officer (SVP and GM, Specialty Products) Shares withheld for taxes / exercise cost 756 $178.68 $135.1K Form 4
2026-02-11 van Gunsteren Job Leonard Officer (SVP and GM, Specialty Products) Grant / award / vesting 1,345 $0.00 $0 Form 4
2026-02-11 van Gunsteren Job Leonard Officer (SVP and GM, Specialty Products) Grant / award / vesting 430 $0.00 $0 Form 4

Ask the chat about BCPC's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: BALCHEM CORP (BCPC).

Last updated 2026-02-12 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.